These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium. Woerner SM, Givehchian M, Dürst M, Schneider A, Costa S, Melsheimer P, Lacroix J, Zöller M, Doeberitz MK. Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903 [Abstract] [Full Text] [Related]
3. Splice variants of CD44 in human cervical cancer stage IB to IIB. Kainz C, Kohlberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, Breitenecker G, Koelbl H. Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775 [Abstract] [Full Text] [Related]
4. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Fujita N, Yaegashi N, Ide Y, Sato S, Nakamura M, Ishiwata I, Yajima A. Cancer Res; 1994 Jul 15; 54(14):3922-8. PubMed ID: 7518345 [Abstract] [Full Text] [Related]
5. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, Zöller J, Bosch FX, Zöller M. J Pathol; 1996 May 15; 179(1):66-73. PubMed ID: 8691348 [Abstract] [Full Text] [Related]
6. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL. Cancer Res; 1994 Aug 15; 54(16):4539-46. PubMed ID: 7519124 [Abstract] [Full Text] [Related]
9. Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Finn L, Dougherty G, Finley G, Meisler A, Becich M, Cooper DL. Biochem Biophys Res Commun; 1994 Apr 29; 200(2):1015-22. PubMed ID: 7513991 [Abstract] [Full Text] [Related]
10. New CD44 splice variants associated with human breast cancers. Iida N, Bourguignon LY. J Cell Physiol; 1995 Jan 29; 162(1):127-33. PubMed ID: 7529235 [Abstract] [Full Text] [Related]
11. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma. Ermak G, Jennings T, Robinson L, Ross JS, Figge J. Cancer Res; 1996 Mar 01; 56(5):1037-42. PubMed ID: 8640758 [Abstract] [Full Text] [Related]
12. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D. Cancer Res; 1994 Aug 01; 54(15):4238-42. PubMed ID: 7518353 [Abstract] [Full Text] [Related]
14. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis. Givehchian M, Woerner SM, Lacroix J, Zöller M, Drings P, Becker H, Kayser K, Ridder R, von Knebel Doeberitz M. Oncogene; 1996 Mar 07; 12(5):1137-44. PubMed ID: 8649806 [Abstract] [Full Text] [Related]
16. CD44 variant exon epitopes in primary breast cancer and length of survival. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. Lancet; 1995 Mar 11; 345(8950):615-9. PubMed ID: 7534855 [Abstract] [Full Text] [Related]
17. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations. Weber B, Rösel M, Arch R, Möller P, Zöller M. Differentiation; 1996 Mar 11; 60(1):17-29. PubMed ID: 8935925 [Abstract] [Full Text] [Related]